AI癌症公司Renovaro Inc.在股票价格恢复后重新获得Nasdaq的遵守。 Renovaro Inc., an AI cancer company, regains Nasdaq compliance after stock price recovery.

一家使用AI进行癌症诊断和治疗的公司Renvaro Inc.已恢复遵守Nasdaq的最低投标价格要求。 Renovaro Inc., a company focusing on cancer diagnostics and therapeutics using AI, has regained compliance with Nasdaq's minimum bid price requirement. 该公司此前曾于9月收到通知,其股票价格跌至每股1美元以下,这是列入Nasdaq公司名单所必需的。 The company had previously received a notice in September that its stock price fell below $1.00 per share, which is required for listing on the Nasdaq. 现在Renovaro符合上市标准,确保其股票可以继续在市场上交易. Renovaro now meets the listing criteria, ensuring its shares can continue trading on the market.